1.1 Specimen Collection, Preanalytical Variables, and Interferences

Specimen Collection, Preanalytical Variables, and Interferences

In the modern clinical diagnostic laboratory, up to 60% to 70% of all diagnostic testing errors occur during the preanalytical phase—prior to the actual analytical aspiration of specimen on an automated analyzer. For the medical technologist preparing for the Philippine Medical Technologists Licensure Examination (MTLE) and international certifications (such as ASCPi), mastering preanalytical principles is essential. Recognizing specimen integrity compromises, understanding anticoagulant chemistry, and preventing additive carryover directly safeguard patient safety and clinical decision-making.

---

1. Venipuncture Order of Draw (CLSI GP41, formerly H3)

The Clinical and Laboratory Standards Institute (CLSI) standard GP41 (which replaced H3-A6) establishes the recommended sequence for collecting blood specimens in multi-tube evacuated blood collection systems (e.g., Vacutainer). The explicit objective of the order of draw is to prevent cross-contamination of tube additives between collection tubes, which can cause profound analytical interference and spurious patient results.

Biochemical Rationale for the Sequence

1. Sterility First: Blood culture vials are drawn first to prevent skin surface microbes or chemical additives from entering culture media, avoiding contaminated blood cultures.
2. Coagulation Integrity: Sodium citrate requires an unactivated sample. If drawn after clot activator tubes (red/SST), tissue factor or silica particles could enter the needle bevel, triggering premature clot cascade activation and falsely shortening coagulation times. When utilizing a winged blood collection set (butterfly needle), a discard tube (clear or non-additive red) must always be drawn first to prime the tubing air space (approx. $0.5\text{ mL}$) and preserve the precise 9:1 blood-to-citrate ratio.
3. EDTA Placement After Heparin and Serum: If an EDTA tube is drawn before a serum or heparin chemistry tube, micro-droplets on the needle puncture septum will introduce potassium and chelating agents into the chemistry sample. This causes disastrous artifactual hyperkalemia (potassium exceeding $8.0\text{ mmol/L}$), profound hypocalcemia ($Ca^{2+} < 2.0\text{ mg/dL}$ or unmeasurable), and inactivation of divalent-cation-dependent enzymes (alkaline phosphatase, amylase).
4. Fluoride/Oxalate Last: Gray-top tubes contain potassium oxalate (which precipitates calcium) and sodium fluoride (which denatures proteins and binds magnesium). Drawing this tube last prevents cell membrane destruction and enzyme inhibition in preceding tubes.

---

2. Anticoagulants and Biochemical Mechanisms of Action

Clinical chemistry testing predominantly utilizes serum (liquid portion of clotted blood) or plasma (liquid portion of unclotted, anticoagulated blood containing fibrinogen). The choice of anticoagulant determines analytical validity:

Ethylenediaminetetraacetic Acid (EDTA)

• Mechanism: Chelates free ionized calcium ($Ca^{2+}$) and magnesium ($Mg^{2+}$), forming a soluble hexadentate chelate that blocks the calcium-dependent coagulation cascade at multiple stages (Factors II, VII, IX, and X).
• Formulations: CLSI recommends spray-dried dipotassium EDTA ($K_2\text{EDTA}$) in plastic tubes. Tripotassium EDTA ($K_3\text{EDTA}$) in liquid form causes significant erythrocyte shrinkage (1% to 2% volume contraction) due to hyperosmolar fluid shifts, slightly depressing hematocrit.
• Chemistry Incompatibilities: EDTA is strictly contraindicated for clinical chemistry panels. It binds $Mg^{2+}$ and $Zn^{2+}$ (obligate cofactors for Alkaline Phosphatase, ALP) and $Ca^{2+}$ (the activator of Amylase), producing falsely low or near-zero enzyme activity. It introduces massive exogenous potassium ($K^+$), spuriously elevating measured serum potassium.

Heparin

• Mechanism: Accelerates the inhibitory activity of plasma Antithrombin III (AT-III) by over 1,000-fold. The heparin-AT-III complex neutralizes serine proteases, primarily Thrombin (Factor IIa) and Factor Xa, halting fibrinogen-to-fibrin conversion.
• Formulations: Lithium heparin, sodium heparin, and ammonium heparin.
• Chemistry Applications: Lithium heparin is the anticoagulant of choice for emergency and routine chemistry testing. It does not introduce cations that interfere with routine electrolyte panels ($Na^+, K^+$). Sodium heparin must never be used for electrolyte profiles. Ammonium heparin falsely elevates blood urea nitrogen (BUN) when analyzed via the urease-Berthelot reaction.
• Molecular Restriction: Heparin inhibits Taq DNA polymerase and is strictly unacceptable for polymerase chain reaction (PCR) amplification assays.

Sodium Citrate

• Mechanism: Chelates ionic calcium to form soluble, unionized calcium citrate complexes. Prepared as a 3.2% (0.109 M) buffered solution in a rigid 9:1 volume ratio of whole blood to anticoagulant.
• Underfilling Consequence: Underfilled blue-top tubes have an excess of free citrate relative to plasma. This excess citrate binds reagent calcium added during the prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays, causing artifactual prolongation of clotting times.

Sodium Fluoride / Potassium Oxalate

• Mechanism of Glycolytic Inhibition: Sodium fluoride ($NaF$) inhibits enolase (phosphopyruvate hydratase), a magnesium-dependent metalloenzyme in the Embden-Meyerhof glycolytic pathway, by generating a magnesium fluorophosphate complex.
• Glycolytic Rate: In unpreserved whole blood at room temperature ($20\text{--}25^\circ\text{C}$), erythrocytes and leukocytes metabolize glucose at a rate of approximately 5% to 7% per hour (approx. $5\text{--}10\text{ mg/dL/hr}$ or $0.28\text{--}0.56\text{ mmol/L/hr}$). In specimens with severe leukocytosis or bacteremia, glycolysis accelerates dramatically. Sodium fluoride stabilizes glucose levels for up to 48 to 72 hours.
• Co-additive Role: Because sodium fluoride is a weak anticoagulant that acts slowly, it is paired with potassium oxalate, which rapidly precipitates ionic calcium as insoluble calcium oxalate monohydrate ($CaC_2O_4 \cdot H_2O$).

---

3. Preanalytical Physiological Variables and Patient Preparation

Patient preparation and collection mechanics introduce biological variations that mimic disease states if unstandardized:

Fasting State and Diet

• Standard Fasting Interval: 8 to 12 hours (water permitted). Strict fasting is mandatory for Fasting Plasma Glucose (FPG) and Lipid Profiles (especially triglycerides).
• Postprandial Effects: Ingestion of a meal stimulates transient increases in glucose ($+20\text{--}50\text{ mg/dL}$), insulin, triglycerides (up to several hundred percent due to intestinal chylomicron secretion), and serum gastrin. Alkaline tide transiently increases urinary pH.
• Prolonged Starvation (>48 hours): Hepatic glycogen stores deplete within 24 hours, triggering lipolysis and ketogenesis. Serum fatty acids and ketone bodies (acetoacetate, $\beta$-hydroxybutyrate) surge. Serum unconjugated bilirubin increases significantly due to fasting-induced mobilization and competitive displacement at the organic anion transporter in individuals with Gilbert syndrome. Albumin, transferrin, and prealbumin decline.

Diurnal (Circadian) Rhythms

• Cortisol: Demonstrates a prominent morning peak between 06:00 and 08:00 AM ($5\text{--}25\ \mu\text{g/dL}$) and declines to a nadir near midnight ($<5\ \mu\text{g/dL}$ or $<50\%$ of the morning peak). Adrenocorticotropic hormone (ACTH) follows an identical diurnal secretory burst.
• Serum Iron: Concentrations are 30% to 50% higher in the early morning compared to evening draws, influenced by reticuloendothelial iron processing rhythms.
• Growth Hormone and Melatonin: Peak during deep slow-wave sleep.

Postural and Positional Shifts

• Physiological Mechanism: Shifting from a recumbent (supine) position to an upright (sitting or standing) posture increases venous hydrostatic capillary pressure, driving water and diffusible electrolytes out of the intravascular space into the interstitial fluid.
• Concentration Changes: Non-diffusible high-molecular-weight molecules and cellular elements undergo relative hemoconcentration. Sitting upright for 15 minutes increases Total Protein, Albumin, Enzymes, Cholesterol, Triglycerides, and protein-bound Calcium by 5% to 15%. To standardize measurements, ambulatory outpatients should remain seated comfortably for at least 10 minutes prior to phlebotomy.

Prolonged Tourniquet Application

• Strict Limit: Tourniquet application must never exceed one minute ($<60\text{ seconds}$).
• Pathophysiology of Stasis: Prolonged venous occlusion increases capillary filtration pressure, forcing water and crystalloids into surrounding tissue. The localized hypoxia drives tissue cells into anaerobic glycolysis, causing accumulation of lactic acid and a localized drop in blood pH. Endothelial shear stress promotes platelet activation and release of intracellular contents.
• Analytical Impact: Marked false increases in total protein, albumin, total calcium, cholesterol, and enzymes. Concurrently, prolonged stasis or vigorous fist-pumping induces localized micro-hemolysis and cellular leakage, spuriously elevating potassium ($K^+$) by $0.5\text{ to }1.5\text{ mmol/L}$.

---

4. Major Analytical Interferences: Mechanisms and Management

Serum indices—Hemolysis (H), Icterus (I), and Lipemia (L)—represent the three primary endogenous spectrophotometric and chemical interferences in clinical chemistry:

                          ┌──────────────────────────────────────────────┐
                          │     Serum Specimen Visual / Spectroscopic    │
                          │                 Interference                 │
                          └──────────────────────┬───────────────────────┘
                                                 │
         ┌───────────────────────────────────────┼──────────────────────────────────────┐
         ▼                                       ▼                                      ▼
  ┌──────────────┐                       ┌──────────────┐                       ┌──────────────┐
  │  Hemolysis   │                       │   Icterus    │                       │   Lipemia    │
  │  (Free Hb)   │                       │ (Bilirubin)  │                       │(Chylomicrons)│
  └──────┬───────┘                       └──────┬───────┘                       └──────┬───────┘
         │                                      │                                      │
  Intracellular Leakage:                 Spectral Overlap:                      Light Scattering:
  • Massive ↑: K+, LD, AST               • Broad peak: 400-500 nm               • Turbidity across 340-700 nm
  • Significant ↑: Mg2+, P04             • Interferes: ALP, ALT                 • Falsely ↑ transmission assays
  Spectral Interference:                 Chemical Interference:                 Electrolyte Exclusion Effect:
  • Soret band: 415 nm                   • Scavenges H2O2 in Trinder            • Displaces plasma water fraction
  • Q bands: 540, 575 nm                   peroxidase assays:                   • Falsely ↓ Na+, Cl- on
  Chemical Quenching:                      - Falsely ↓ Glucose                     indirect ISE
  • Bilirubin diazo inhibition             - Falsely ↓ Cholesterol              Corrective Strategy:
  Corrective Strategy:                     - Falsely ↓ Triglycerides            • High-speed ultracentrifugation
  • Specimen re-collection               Corrective Strategy:                     (Airfuge at >100,000 x g)
  • Automated H-index cutoffs            • Sample blanking                      • Direct ISE (undiluted)
                                         • Dual-wavelength bichromatic          • Lipoclear chemical extraction

Hemolysis

• Definition: In vitro rupture of erythrocyte membranes releasing free hemoglobin and intracellular cytoplasmic enzymes into serum or plasma. Hemolysis becomes visible once free hemoglobin reaches roughly $0.2\text{--}0.3\text{ g/L}$ ($20\text{--}30\text{ mg/dL}$), imparting a pink-to-red discoloration.
• Intracellular Release Mechanism: Mature erythrocytes maintain steep transmembrane concentration gradients powered by $Na^+/K^+$-ATPase pumps. Rupture releases:
  • Potassium ($K^+$): Erythrocyte intracellular concentration is $\approx 100\text{--}105\text{ mmol/L}$ versus serum levels of $3.5\text{--}5.0\text{ mmol/L}$ (a gradient of more than 20-fold). Even mild hemolysis falsely elevates serum potassium to life-threatening ranges.
  • Lactate Dehydrogenase (LD): Red cells contain approximately 160-fold higher LD concentrations (predominantly the fast-migrating $LD_1$ and $LD_2$ tetramers), so even slight hemolysis raises serum LD measurably.
  • Aspartate Aminotransferase (AST): Approximately 40-fold intracellular excess; ALT rises far less because red cells contain only about 7 times the plasma ALT activity.
  • Magnesium ($Mg^{2+}$) and Inorganic Phosphorus: Moderately concentrated in erythrocytes, causing noticeable false elevations.
• Spectrophotometric and Chemical Interference: Free oxyhemoglobin features intense absorption bands: the Soret band at $415\text{ nm}$, and secondary $\alpha$ and $\beta$ bands at $540\text{ nm}$ and $575\text{ nm}$. It directly elevates absorbance in colorimetric tests reading at these wavelengths (such as alkaline picrate Jaffe creatinine assays and biuret total protein). Chemically, free hemoglobin binds to and inhibits diazonium salts, causing falsely decreased total and conjugated bilirubin in Malloy-Evelyn or Jendrassik-Grof assays.

Icterus (Bilirubinemia)

• Mechanism: Elevated conjugated or unconjugated bilirubin imparts an intense amber-to-brown coloration when total bilirubin exceeds $2.0\text{ to }2.5\text{ mg/dL}$ ($34\text{--}43\ \mu\text{mol/L}$).
• Spectral Interference: Bilirubin exhibits a wide molar absorptivity band between $400\text{ nm}$ and $500\text{ nm}$ (absorbance peak at $\approx 456\text{ nm}$). This overlaps with continuous-monitoring enzyme assays that track $p$-nitrophenol formation at $405\text{ nm}$ (e.g., Alkaline Phosphatase).
• Chemical Interference (Trinder Reaction Suppression): Bilirubin is a powerful antioxidant reducing agent. In enzymatic assays coupled with horseradish peroxidase (HRP)—including glucose oxidase ($GOD\text{-}PAP$), cholesterol oxidase, triglyceride glycerol phosphate oxidase, and uricase assays—intermediate hydrogen peroxide ($H_2O_2$) oxidizes a phenolic or aniline chromogen. Bilirubin competitively consumes $H_2O_2$, drastically suppressing quinoneimine dye production and causing falsely decreased glucose, cholesterol, triglycerides, and uric acid.
• Correction: Application of sample-blanking (measuring baseline specimen absorbance prior to adding the chromogenic reagent), dual-wavelength bichromatic spectrophotometry (measuring at $505\text{ nm}$ and subtracting background at $600\text{ nm}$), or pre-treating with bilirubin oxidase.

Lipemia

• Mechanism: Turbidity and opacity in serum caused by accumulation of large lipoprotein particles, primarily chylomicrons (diameter $75\text{--}1200\text{ nm}$) following meals, or elevated very-low-density lipoproteins (VLDL) in type IV/V hyperlipoproteinemia with triglycerides $>400\text{ mg/dL}$ ($>4.5\text{ mmol/L}$). Light chylomicrons form a distinct creamy floating layer upon refrigeration at $4^\circ\text{C}$ overnight.
• Physical Light Scattering: Particles scatter light across the entire UV and visible spectrum ($340\text{ to }700\text{ nm}$), falsely increasing apparent absorbance in all transmission spectrophotometric methods.
• Electrolyte Exclusion Effect (Volume Displacement):
  • Normal plasma is composed of 93% water and 7% non-aqueous solids (lipids and proteins). Soluble hydrophilic electrolytes ($Na^+, Cl^-$) dissolve exclusively in the 93% aqueous fraction.
  • In severe hypertriglyceridemia (or extreme hyperproteinemia in multiple myeloma), lipids displace water, expanding the solid non-aqueous volume well beyond the normal 7% (to 10% to 20% in extreme cases) and shrinking the water phase accordingly.
  • Indirect Ion-Selective Electrodes (Indirect ISE)—the standard module on automated high-throughput chemistry analyzers—dilute a fixed aliquot of total patient serum (e.g., 1:20 or 1:30) with diluent buffer before the sample contacts the ion-selective membrane. The diluted aliquot contains less aqueous volume, leading to artifactual pseudohyponatremia and pseudohypochloremia.
  • Direct Ion-Selective Electrodes (Direct ISE)—utilized in blood gas analyzers and critical-care point-of-care instruments—measure the undiluted specimen directly. Direct ISE measures the true electrochemical activity of sodium in the aqueous phase and is completely unaffected by lipid displacement.
• Corrective Clearing Techniques: Ultracentrifugation via high-speed Airfuge ($100,000 \times g$) clears chylomicrons, leaving a transparent infranatant for analysis. Chemical clarification using cyclodextrins (e.g., Lipoclear) precipitates lipoproteins, though chemical clearing agents alter lipid-soluble analytes (fat-soluble vitamins, hormones, and therapeutic drugs).